The amendments of item 3 of the table in Schedule 5A made by Part 2 of Schedule 1 to the Therapeutic Goods Legislation Amendment (2023 easures No. 1) Regulations 2023 apply in relation to the use of therapeutic goods on or after the commencement of those amendments, whether the clinical trial began before, on or after that commencement.